Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PS O-39:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004300 AN007153 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007153 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST004300 AN007155 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007155 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST003769 AN006189 Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease Brain Human Alzheimers disease University of Melbourne LC-MS
ST001795 AN002916 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) Mesenteric lymph Mouse Obesity Monash Institute of Pharmaceutical Sciences LC-MS
  logo